|
SP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.28880017769006E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.99969999950633E-07 |
| Normal-vs-Stage2 |
1.208000E-02 |
| Normal-vs-Stage3 |
1.180260E-02 |
| Normal-vs-Stage4 |
3.358600E-01 |
| Stage1-vs-Stage2 |
7.531200E-01 |
| Stage1-vs-Stage3 |
7.007000E-01 |
| Stage1-vs-Stage4 |
4.752400E-01 |
| Stage2-vs-Stage3 |
5.838000E-01 |
| Stage2-vs-Stage4 |
4.441800E-01 |
| Stage3-vs-Stage4 |
6.644800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.41420003169679E-09 |
| Normal-vs-AfricanAmerican |
1.69857999999801E-05 |
| Normal-vs-Asian |
7.446400E-01 |
| Caucasian-vs-AfricanAmerican |
5.398600E-01 |
| Caucasian-vs-Asian |
2.122200E-01 |
| AfricanAmerican-vs-Asian |
1.502990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.91300008956352E-10 |
| Normal-vs-Female |
1.76783999999985E-05 |
| Male-vs-Female |
7.476400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.740500E-03 |
| Normal-vs-Extreme_Weight |
6.163600E-04 |
| Normal-vs-Obese |
4.36650000046335E-07 |
| Normal-vs-Extreme_Obese |
3.262600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.937200E-01 |
| Normal_Weight-vs-Obese |
6.307800E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.313400E-01 |
| Extreme_Weight-vs-Obese |
6.892300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.504600E-01 |
| Obese-vs-Extreme_Obese |
1.302650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.282500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.60719992869929E-10 |
| Normal-vs-Age(61-80Yrs) |
1.98121999999135E-05 |
| Normal-vs-Age(81-100Yrs) |
1.729600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.294600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.778000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.689000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.471740E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.688230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.149000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.64512847788956E-12 |
| Normal-VS-Type2 PRCC |
2.379800E-01 |
| Normal-VS-KIRP CIMP |
4.597800E-01 |
| Normal-VS-Unclassified PRCC |
1.024920E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.228999997557E-08 |
| Type1 PRCC-VS-KIRP CIMP |
5.648700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.950000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.001600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.080500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.802600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.155300E-03 |
| Normal-vs-N1 |
1.708400E-02 |
| Normal-vs-N2 |
6.184300E-02 |
| N0-vs-N1 |
3.124200E-01 |
| N0-vs-N2 |
8.976200E-01 |
| N1-vs-N2 |
3.378000E-01 |
|
|
